Tissue Is Not Always the Issue: A New Era and Expanding Armamentarium of Histology-Agnostic Targeted Therapies for Solid Tumors

Get up to date on the optimal assessment of histology-agnostic biomarkers and their impact on therapeutic planning across tumor types with this comprehensive educational program featuring an on-demand webcast, downloadable slidesets, and FAQ commentary from a live expert-led symposium along with a summary clinical resource PDF to download for use in your clinic.

Share

Program Content

Activities

Histology-Agnostic Biomarker Testing in Cancer Care
Histology-Agnostic Biomarker Assessment and Impact on Cancer Care
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2023

Expires: June 05, 2024

Histology-Agnostic Biomarkers for Immunotherapy
Histology-Agnostic Biomarkers for Immunotherapy in Cancer Care
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2023

Expires: June 05, 2024

Histology-Agnostic Biomarkers for Targeted Therapy
Histology-Agnostic Biomarkers for Targeted Therapy in Cancer Care
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2023

Expires: June 05, 2024

Activities

Targeted Therapies for Solid Tumors
Tissue Is Not Always the Issue: Expanding Armamentarium of Histology-Agnostic Targeted Therapies for Solid Tumors
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 20, 2023

Expires: June 19, 2024

Activities

Histology Agnostic FAQs
Histology-Agnostic Therapies for Solid Tumors: Experts Answer Frequently Asked Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2023

Expires: July 30, 2024

Activities

Histology-Agnostic Therapies
Histology-Agnostic Therapies: Clinical Pearls for Practice
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2023

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from Aadi Bioscience, Bayer HealthCare Pharmaceuticals Inc., and Lilly.

Aadi Bioscience

Bayer HealthCare Pharmaceuticals Inc.

Lilly